Cargando…
Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation
BACKGROUND: Chronic constipation is a common condition, but the exact impact on healthcare budgets in Western Europe is poorly documented. OBJECTIVES: The aim of this study was to (a) investigate chronic constipation-related direct medical costs in patients with newly diagnosed chronic constipation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186732/ https://www.ncbi.nlm.nih.gov/pubmed/25229982 http://dx.doi.org/10.1097/MEG.0000000000000167 |
_version_ | 1782338105710215168 |
---|---|
author | Dik, Vincent K. Siersema, Peter D. Joseph, Alain Hodgkins, Paul Smeets, Hugo M. van Oijen, Martijn G.H. |
author_facet | Dik, Vincent K. Siersema, Peter D. Joseph, Alain Hodgkins, Paul Smeets, Hugo M. van Oijen, Martijn G.H. |
author_sort | Dik, Vincent K. |
collection | PubMed |
description | BACKGROUND: Chronic constipation is a common condition, but the exact impact on healthcare budgets in Western Europe is poorly documented. OBJECTIVES: The aim of this study was to (a) investigate chronic constipation-related direct medical costs in patients with newly diagnosed chronic constipation and (b) study differences in costs according to natural history. PATIENTS AND METHODS: We identified 16 887 patients newly diagnosed with chronic constipation in a Dutch health insurance database (∼1.3 million patients) in 2006–2009. Individuals with chronic constipation were selected on the basis of chronic laxative use (≥90 days/year) and diagnostic related groups for chronic constipation. On the basis of the episodes of laxative use and diagnostic related groups, individuals were categorized as having persistent, episodic, and nonrecurrent disease. Unadjusted costs for laxatives and hospital care for chronic constipation and constipation-related comorbidities were assessed and compared between patients with nonrecurrent, episodic, and persistent disease. Factors associated with costs were identified using Cox regression analyses. RESULTS: The mean total chronic constipation-related direct medical costs in the first year after diagnosis were €310±845 and consisted of laxatives (45%) and hospital care for chronic constipation (26%) as well as constipation-related comorbidities (29%). Costs were highest in patients with persistent disease (€367±882) compared with patients with episodic (€292±808) and nonrecurrent (€263±613) disease (P<0.01). Male sex was associated with higher costs, whereas increasing age, diabetes, and use of opioids were associated with lower costs. CONCLUSION: Pharmacy costs and hospital care costs for chronic constipation-related comorbidities were the largest cost drivers for total constipation-related direct medical costs in patients with newly diagnosed chronic constipation. Direct medical costs differed according to patient characteristics. |
format | Online Article Text |
id | pubmed-4186732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Lippincott Williams And Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-41867322014-10-08 Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation Dik, Vincent K. Siersema, Peter D. Joseph, Alain Hodgkins, Paul Smeets, Hugo M. van Oijen, Martijn G.H. Eur J Gastroenterol Hepatol Original Articles: Functional Disorders BACKGROUND: Chronic constipation is a common condition, but the exact impact on healthcare budgets in Western Europe is poorly documented. OBJECTIVES: The aim of this study was to (a) investigate chronic constipation-related direct medical costs in patients with newly diagnosed chronic constipation and (b) study differences in costs according to natural history. PATIENTS AND METHODS: We identified 16 887 patients newly diagnosed with chronic constipation in a Dutch health insurance database (∼1.3 million patients) in 2006–2009. Individuals with chronic constipation were selected on the basis of chronic laxative use (≥90 days/year) and diagnostic related groups for chronic constipation. On the basis of the episodes of laxative use and diagnostic related groups, individuals were categorized as having persistent, episodic, and nonrecurrent disease. Unadjusted costs for laxatives and hospital care for chronic constipation and constipation-related comorbidities were assessed and compared between patients with nonrecurrent, episodic, and persistent disease. Factors associated with costs were identified using Cox regression analyses. RESULTS: The mean total chronic constipation-related direct medical costs in the first year after diagnosis were €310±845 and consisted of laxatives (45%) and hospital care for chronic constipation (26%) as well as constipation-related comorbidities (29%). Costs were highest in patients with persistent disease (€367±882) compared with patients with episodic (€292±808) and nonrecurrent (€263±613) disease (P<0.01). Male sex was associated with higher costs, whereas increasing age, diabetes, and use of opioids were associated with lower costs. CONCLUSION: Pharmacy costs and hospital care costs for chronic constipation-related comorbidities were the largest cost drivers for total constipation-related direct medical costs in patients with newly diagnosed chronic constipation. Direct medical costs differed according to patient characteristics. Lippincott Williams And Wilkins 2014-11 2014-10-03 /pmc/articles/PMC4186732/ /pubmed/25229982 http://dx.doi.org/10.1097/MEG.0000000000000167 Text en © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/3.0. |
spellingShingle | Original Articles: Functional Disorders Dik, Vincent K. Siersema, Peter D. Joseph, Alain Hodgkins, Paul Smeets, Hugo M. van Oijen, Martijn G.H. Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title | Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title_full | Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title_fullStr | Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title_full_unstemmed | Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title_short | Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
title_sort | constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation |
topic | Original Articles: Functional Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186732/ https://www.ncbi.nlm.nih.gov/pubmed/25229982 http://dx.doi.org/10.1097/MEG.0000000000000167 |
work_keys_str_mv | AT dikvincentk constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation AT siersemapeterd constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation AT josephalain constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation AT hodgkinspaul constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation AT smeetshugom constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation AT vanoijenmartijngh constipationrelateddirectmedicalcostsin16887patientsnewlydiagnosedwithchronicconstipation |